View in EDS HTML Full Text PDF Full Text

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).

Saved in:
Bibliographic Details
Title: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Authors: Inciarte, Alexy1,2,3 (AUTHOR) ajinciar@clinic.cat, Ugarte, Ainoa1 (AUTHOR), Martínez-Rebollar, María1,3,4 (AUTHOR), Torres, Berta1,2,3,4 (AUTHOR), Fernández, Emma1 (AUTHOR), Berrocal, Leire1,2 (AUTHOR), Laguno, Montserrat1,2,3,4 (AUTHOR), Mora, Lorena De la1,3 (AUTHOR), Lazzari, Elisa De1,2,3,4 (AUTHOR), Callau, Pilar2 (AUTHOR), Chivite, Iván1 (AUTHOR), González-Cordón, Ana1 (AUTHOR), Solbes, Estela1 (AUTHOR), Rico, Verónica1 (AUTHOR), Barrero, Laura1 (AUTHOR), Blanco, José Luis1,3,4 (AUTHOR), Martínez, Esteban1,2,3,4 (AUTHOR), Ambrosioni, Juan1,2,3,4 (AUTHOR) ajinciar@clinic.cat, Mallolas, Josep1,2,3,4 (AUTHOR), Group, for the DORAVIPEP Study (AUTHOR)
Source: Open Forum Infectious Diseases. Aug2023, Vol. 10 Issue 8, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofad374